About Rahko
Rahko applies quantum machine learning algorithms to drug discovery and pharmaceutical research, developing quantum-enhanced computational methods for molecular analysis, drug-target interactions, and compound optimization that leverage quantum computing’s potential advantages in exploring complex chemical space for therapeutic applications.
2025 Developments: The company continues to enhance its quantum software platform and developer tools in 2025. Focus remains on improving algorithm efficiency and expanding use case applications. Active engagement with the quantum developer community drives product evolution.
Company Information
- Founded: 2018
- Country: United Kingdom
- Website: https://rahko.ai
- Categories: software
Key People
Nathan Brown (Co-founder, CEO), Leo Canas (Co-founder, CTO)
Related Companies
Explore other quantum computing companies in similar categories or regions.